Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
870K
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
338K
-
Shares change
-
+188K
-
Total reported value, excl. options
-
$65.9K
-
Value change
-
+$26K
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$0.20
Significant Holders of Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) as of Q1 2025
10 filings reported holding PTIX - Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share as of Q1 2025.
Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 338K shares
of 870K outstanding shares and own 38.84% of the company stock.
Largest 10 shareholders include HRT FINANCIAL LP (124K shares), GEODE CAPITAL MANAGEMENT, LLC (77.3K shares), Virtu Financial LLC (55.5K shares), VANGUARD GROUP INC (33.2K shares), TWO SIGMA SECURITIES, LLC (28K shares), STATE STREET CORP (13.8K shares), Tower Research Capital LLC (TRC) (5.92K shares), BANK OF AMERICA CORP /DE/ (54 shares), UBS Group AG (0 shares), and OSAIC HOLDINGS, INC. (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.